Blockade of MCU-Mediated Ca²⁺ Uptake Perturbs Lipid Metabolism via PP4-Dependent AMPK Dephosphorylation

Highlights

• Mitochondrial Ca²⁺ powers FAO-dependent hepatocyte mitochondrial respiration

• Hepatic MCU deletion promotes lipid accumulation and lowers ketone bodies

• Blockade of _mCa²⁺ buffering enhances AMPK dephosphorylation through PP4

• Restoration of AMPK activity in MCU^Δhep model improves lipid clearance

Summary

Mitochondrial Ca²⁺ uniporter (MCU)-mediated Ca²⁺ uptake promotes the buildup of reducing equivalents that fuel oxidative phosphorylation for cellular metabolism. Although MCU modulates mitochondrial bioenergetics, its function in energy homeostasis in vivo remains elusive. Here we demonstrate that deletion of the Mcu gene in mouse liver (MCU^Δhep) and in Danio rerio by CRISPR/Cas9 inhibits mitochondrial Ca²⁺ (_mCa²⁺) uptake, delays cytosolic Ca²⁺ (_cCa²⁺) clearance, reduces oxidative phosphorylation, and leads to increased lipid accumulation. Elevated hepatic lipids in MCU^Δhep were a direct result of extramitochondrial Ca²⁺-dependent protein phosphatase-4 (PP4) activity, which dephosphorylates AMPK. Loss of AMPK recapitulates hepatic lipid accumulation without changes in MCU-mediated Ca²⁺ uptake. Furthermore, reconstitution of active AMPK, or PP4 knockdown, enhances lipid clearance in MCU^Δhep hepatocytes. Conversely, gain-of-function MCU promotes rapid _mCa²⁺ uptake, decreases PP4 levels, and reduces hepatic lipid accumulation. Thus, our work uncovers an MCU/PP4/AMPK molecular cascade that links Ca²⁺ dynamics to hepatic lipid metabolism.